{
  "pmcid": "12484463",
  "sha256": "57e976428043d136ad21b9f536d07a2512d2e70530b9a6f0b6b6f39aad1d8214",
  "timestamp_utc": "2025-11-09T15:44:14.592406+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.977082434182137,
    "reading_ease": 15.758116817724073,
    "word_count": 331
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This equivalence-dose randomized controlled trial evaluated whether liposomal bupivacaine provides non-inferior analgesia to the standard combination when administered via rhomboid intercostal block (RIB)."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this double-blind randomized controlled trial, 90 VATS patients were randomly assigned to receive either..."
      },
      "Participants": {
        "score": 2,
        "evidence": "90 VATS patients were randomly assigned to receive either..."
      },
      "Intervention": {
        "score": 2,
        "evidence": "a 20-ml premixed solution containing 93 mg of liposomal bupivacaine combined with 25 mg of plain bupivacaine (liposomal bupivacaine group), or a 20-ml admixture of 105 mg of plain bupivacaine and 5 mg of dexamethasone (plain bupivacaine with dexamethasone group)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This equivalence-dose randomized controlled trial evaluated whether liposomal bupivacaine provides non-inferior analgesia to the standard combination when administered via rhomboid intercostal block (RIB)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome assessed was the area under the curve (AUC) of the 48-h resting pain numeric rating scale (NRS)."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "In this double-blind randomized controlled trial, 90 VATS patients were randomly assigned to receive either..."
      },
      "Blinding": {
        "score": 2,
        "evidence": "In this double-blind randomized controlled trial..."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "90 VATS patients were randomly assigned to receive either..."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Liposomal bupivacaine was shown to be non-inferior to plain bupivacaine with dexamethasone, with a 48-h NRS AUC of 105.5 ± 13.6 vs . 113.1 ± 16.3 (mean difference − 7.6; 95% CI − 13.9 to − 1.2, upper limit < non-inferiority margin 3.7)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Safety profiles were comparable, with no between-group differences in postoperative nausea and vomiting or other severe complications ( P > 0.05)."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered on ClinicalTrials.gov ( NCT06392191 )."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}